Immunohistochemical Expression of COX2 in Urothelial Carcinoma of the urinary bladder

Background and objectives: Urothelial carcinoma of urinary bladder constitutes 90% of bladder cancer cases. Cyclo-oxygenase 2 as an immune-histochemical marker, is not expressed in normal tissues, while it is expressed in some cancers including urothelial carcinoma. The purpose of this study is det...

Full description

Saved in:
Bibliographic Details
Main Authors: Shayan Khattab Omer, Jalal Ali Jalal, Zheen Othman
Format: Article
Language:English
Published: Kurdistan Higher Council Of Medical Specialties 2024-12-01
Series:Advanced Medical Journal
Subjects:
Online Access:https://amj.khcms.edu.krd/index.php/main/article/view/520
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849698928833855488
author Shayan Khattab Omer
Jalal Ali Jalal
Zheen Othman
author_facet Shayan Khattab Omer
Jalal Ali Jalal
Zheen Othman
author_sort Shayan Khattab Omer
collection DOAJ
description Background and objectives: Urothelial carcinoma of urinary bladder constitutes 90% of bladder cancer cases. Cyclo-oxygenase 2 as an immune-histochemical marker, is not expressed in normal tissues, while it is expressed in some cancers including urothelial carcinoma. The purpose of this study is detecting the frequency of expression of Cyclo-oxygenase 2 in urinary bladder’s urothelial carcinoma in association with certain clinicopathological variables. Methods: A retrospective study was done on seventy-nine cases (fixed with formalin and embedded in paraffin) of urothelial carcinoma which were chosen haphazardly from a private laboratory in Erbil city over two years (between October 2019 to October 2021). In the present study, Cyclo-oxygenase 2 expression was assessed on the urothelial carcinoma slides. Results: Cyclo-oxygenase 2 was positive in 45.6% of the cases. It was positive in 80% of non-papillary tumors, while it was less expressed (40.6%) in papillary tumors, which means that significant correlation was seen between Cyclo-oxygenase 2 positivity and tumor pattern (papillary vs non-papillary) (p = 0.037). In this study, no important association was found between Cyclo-oxygenase 2 expression and other clinicopathologic features like age (p=0.236), gender (p=517), tumor grade (p=0.106), lymphovascular invasion (p=0.696) and T stage (p=0.061). Conclusion: In this study Cyclo-oxygenase 2 was expressed in less than half of our urothelial tumor samples. A strong association was found between Cyclo-oxygenase 2 positivity and tumor pattern (papillary and non-papillary), but no important association was found between Cyclo-oxygenase 2 positivity and other variables such as age, gender, tumor grade, lymphovascular invasion and tumor stage.
format Article
id doaj-art-a5f8526a02bd4664bbd06ce53c8bcc93
institution DOAJ
issn 2958-8979
2957-3580
language English
publishDate 2024-12-01
publisher Kurdistan Higher Council Of Medical Specialties
record_format Article
series Advanced Medical Journal
spelling doaj-art-a5f8526a02bd4664bbd06ce53c8bcc932025-08-20T03:18:45ZengKurdistan Higher Council Of Medical SpecialtiesAdvanced Medical Journal2958-89792957-35802024-12-019410.56056/amj.2024.291521Immunohistochemical Expression of COX2 in Urothelial Carcinoma of the urinary bladderShayan Khattab Omer0Jalal Ali Jalal1Zheen Othman2M.B.Ch.B,SHO of Histopathology in Rizgary Teaching Hospital, trainee of KHCMS, Erbil.M.B.Ch.B, MSc, FIBMS, Consultant Histopathologist in Rizgary Teaching Hospital, Professor in Hawler Medical University- College of Medicine, ErbilM.B.Ch.B, KHCMS, Consultant histopathologist at Hawler Medical University- College of Medicine, Erbil Background and objectives: Urothelial carcinoma of urinary bladder constitutes 90% of bladder cancer cases. Cyclo-oxygenase 2 as an immune-histochemical marker, is not expressed in normal tissues, while it is expressed in some cancers including urothelial carcinoma. The purpose of this study is detecting the frequency of expression of Cyclo-oxygenase 2 in urinary bladder’s urothelial carcinoma in association with certain clinicopathological variables. Methods: A retrospective study was done on seventy-nine cases (fixed with formalin and embedded in paraffin) of urothelial carcinoma which were chosen haphazardly from a private laboratory in Erbil city over two years (between October 2019 to October 2021). In the present study, Cyclo-oxygenase 2 expression was assessed on the urothelial carcinoma slides. Results: Cyclo-oxygenase 2 was positive in 45.6% of the cases. It was positive in 80% of non-papillary tumors, while it was less expressed (40.6%) in papillary tumors, which means that significant correlation was seen between Cyclo-oxygenase 2 positivity and tumor pattern (papillary vs non-papillary) (p = 0.037). In this study, no important association was found between Cyclo-oxygenase 2 expression and other clinicopathologic features like age (p=0.236), gender (p=517), tumor grade (p=0.106), lymphovascular invasion (p=0.696) and T stage (p=0.061). Conclusion: In this study Cyclo-oxygenase 2 was expressed in less than half of our urothelial tumor samples. A strong association was found between Cyclo-oxygenase 2 positivity and tumor pattern (papillary and non-papillary), but no important association was found between Cyclo-oxygenase 2 positivity and other variables such as age, gender, tumor grade, lymphovascular invasion and tumor stage. https://amj.khcms.edu.krd/index.php/main/article/view/520COX2ImmunohistochemistryUrothelial carcinoma
spellingShingle Shayan Khattab Omer
Jalal Ali Jalal
Zheen Othman
Immunohistochemical Expression of COX2 in Urothelial Carcinoma of the urinary bladder
Advanced Medical Journal
COX2
Immunohistochemistry
Urothelial carcinoma
title Immunohistochemical Expression of COX2 in Urothelial Carcinoma of the urinary bladder
title_full Immunohistochemical Expression of COX2 in Urothelial Carcinoma of the urinary bladder
title_fullStr Immunohistochemical Expression of COX2 in Urothelial Carcinoma of the urinary bladder
title_full_unstemmed Immunohistochemical Expression of COX2 in Urothelial Carcinoma of the urinary bladder
title_short Immunohistochemical Expression of COX2 in Urothelial Carcinoma of the urinary bladder
title_sort immunohistochemical expression of cox2 in urothelial carcinoma of the urinary bladder
topic COX2
Immunohistochemistry
Urothelial carcinoma
url https://amj.khcms.edu.krd/index.php/main/article/view/520
work_keys_str_mv AT shayankhattabomer immunohistochemicalexpressionofcox2inurothelialcarcinomaoftheurinarybladder
AT jalalalijalal immunohistochemicalexpressionofcox2inurothelialcarcinomaoftheurinarybladder
AT zheenothman immunohistochemicalexpressionofcox2inurothelialcarcinomaoftheurinarybladder